A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: Possible correlation with poor response to fetal therapy

Prenatal Diagnosis

Volumn 28, Issue 11, 2008, Pages 1057-1063

  Ma, Gwo Chin ^a,c   Liu, Chin San ^a   Chang, Shun Ping ^a   Yeh, Kun Tu ^a   Ke, Yu Yuan ^a   Chen, Tze Ho ^a   Wang, Boris Bao Tyan ^a,d   Kuo, Shou Jen ^a   Shih, Jin Chung ^b   Chen, Ming ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Chylothorax; Integrins; OK 432

Indexed keywords

ALPHA INTEGRIN; PICIBANIL;

ALLELE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHYLOTHORAX; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FETAL THERAPY; FETUS; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PLEURODESIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

AMINO ACID SEQUENCE; ANIMALS; CHYLOTHORAX; DOGS; FEMALE; FETAL THERAPIES; FORKHEAD TRANSCRIPTION FACTORS; GENOTYPE; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PAN TROGLODYTES; PICIBANIL; PREGNANCY; PROTEIN CONFORMATION; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 57349189618     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2130     Document Type: Article

References (25)

1. Bartha JL, Comino-Delgado R. 2001. Fetal chylothorax response to maternal dietary treatment. Obstet Gynecol 97: 820-823.
2. Chen CP. 2005a. Fetal therapy and cytogenetic testing: prenatal detection of chromosome aberration during thoracocentesis for congenital chylothorax by karyotyping from pleural effusion fluid and review of the literature. Genet Courts 16: 301-305.
3. Chen M, Chen CP, Shih JC, Chou HC, Yu CL, Hsieh CY. 2005b. Antenatal treatment of chylothorax and cystic hygroma with OK432 in non-immune hydrops fetalis. Fetal Diagn Ther 20: 309-315.
4. Chen M, Shih JC, Wang BT, Chen CP, Yu CL. 2005c. Fetal OK-432 pleurodesis: complete or incomplete? Ultrasound Obstet Gynecol 26: 791-793.
5. Chen M, Hsieh CY, Shih JC, et al. 2007. Proinflammatory macrophage migratory inhibition factor and interleukin-6 are concentrated in pleural effusion of human fetuses with prenatal chylothorax. Prenat Diagn 27: 435-441.
6. Daniel-Spiegel E. Ghalamkarpour A, Spiegel R, et al. 2005. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn 25: 1015-1018.
7. Fang J. Dagenais SL, Erickson RP, et al. 2000. Mutation in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67: 1382-1388.
8. Gleeson JG, Minnerath S, Juzniecky RI, et al. 2000. Somatic and germline mosaic mutations in the doublecortin gene are associated with variable phenotypes. Am J Hum Genet 67: 574-581.
9. 2 subunit. Proc Natl Acad Sci U S A 94: 3162-3167.
10. Huang XZ, Wu JF, Ferrando R, et al. 2000. Fatal bilateral chylothorax in mice lacking the integrin alpha9betal. Mol Cell Biol 20: 5208-5215.
11. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
12. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. 2000. Congenital hereditary lymphedea caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67: 295-301.
13. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. 2000. Missense mutations interfere with VEGFR-3 signaling in primary lymphoedema. Nat Genet 25: 153-159.
14. Lund O, Nielsen M, Lundegaard C, Worning P. 2002. CPH Model 2.0: X3M a computer program to extract 3D models. Abstract at the CASP5 conferenceA102.
15. Ma GC, Chang SP, Chen M, Kuo SJ, Chang CS, Shen MC. 2008. The spectrum of factor 8 (F8) defects in Taiwanese patients with hemophilia A. Haemophilia 14: 787-795.
16. Nygaard U, Sundberg K, Sci DM, Nielsen HS, Hertel S, Joørgensen C. 2007. New treatment of early fetal chylothorax. Obstet Gynecol 109: 1088-1092.
17. Parra J, Amenedo M, Mǔniz-Dǐaz E, et al. 2003. A new successful therapy for fetal chylothorax by intrapleural injection of maternal blood. Ultrasound Obstet Gynecol 22: 290-294.
18. Picone O, Benachi A, Mandelbrodt L, Ruano R, Dumez Y, Dommergues M. 2004. Thoracoamniotic shunting for fetal pleural effusions with hydrops. Am J Obstet Gynecol 191: 2047-2050.
19. Reichardt LF, Tomaselli KJ. 1991. Extracellular matrix molecules and their receptors: functions in neural development. Annu Rev Neurosci 14: 531-570.
20. Schneider M, Joncourt F, Sanz J, von Känel T, Gallati S. 2006. Detection of exon deletions within an entire gene (CFTR) by relative quantification on the lightcycler. Clin Chem 52: 2005-2012.
21. Smeltzer DM, Stickler GB, Fleming RE. 1986. Primary lymphatic dysplasia in children: Chylothorax, chylous ascites, and generalized lymphatic dysplasia. Eur J Pediatr 45: 286-292.
22. Stevenson DA, Pysher TJ, Ward RM, Carey JC. 2006. Familial congenital non-immuno hydrops, chylothorax, and pulmonary lymphangiectasia. Am J Med Genet 140A: 368-372.
23. Traboulsi EI, AI-Khayer K, Matsumoto M, et al. 2002. Lymphedema-distichiasis syndrome and FOXC2 gene mutation. Am J Hum Ophthalmol 134: 592-596.
24. Van Straaten HLM, Gerards LJ, Krediet TG. 1993. Chylothorax in the neonatal period. Eur J Pediatr 152: 2-5.
25. Weber AM, Philipson EH. 1992. Fetal pleural effusion: a review and meta-analysis for prognostic indicators. Obstet Gynecol 79: 281-286.